ARCHIVES

Decision To Stop NSABP P-4 Study Before It Starts Shocks Clinical Trialists.

This article is from The Cancer Letter archive.

Vol. 33 No. 08 | March 2, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

FY09 Proposal for NIH Flat. NCI “Bypass Budget” Makes Case for $6 Billion.

February 8, 2008

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

May 22, 2009

MD Anderson President Ronald DePinho: “Some of the Feedback was Humbling”

March 29, 2013

Georgetown Sponsors Oncology Agent Development Meeting

February 21, 2003

Cancers Linked To Agent Orange In IOM Review

August 13, 1993